PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN).
Abstract
Authors
J. Turnes D. Rincon Rodriguez J.L. Calleja M. Delgado J.M. Rosales-Zabal R. Andrade M.L. Manzano Alonso J. Salmeron Escobar M.A. Lopez garrido M. Calvo Sanchez J. Gomez Camarero E. Molina Perez A. Olveira Martin